CRENEZUMAB

UNII: O8AS5277H0
Preferred Substance Name: CRENEZUMAB

1095207-05-8
CRENEZUMAB [INN]
CRENEZUMAB [JAN]
CRENEZUMAB [USAN]
CRENEZUMAB [WHO-DD]
IMMUNOGLOBULIN G4, ANTI-(HUMAN 1-40-.BETA.-AMYLOID/HUMAN 1-42-.BETA.-AMYLOID) (HUMAN-MOUSE MONOCLONAL MABT5102A HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL MABT5102A LIGHT CHAIN, DIMER
MABT5102A
MABT-5102A
RG7412
RG-7412

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

CRENEZUMAB

Synonyms and Mappings

Resources

Note